PROCEPT BioRobotics Corp
PRCT Nasdaq
SEC CIK 1588978
Follow PROCEPT BioRobotics
Weekly email: filings, results
Revenue, last quarter
$98.3M
+18% vs same quarter last year
Net income
−$26.5M
−23.8% vs same quarter last year
EPS, diluted
−$0.46
−21.1% vs same quarter last year
Operating cash flow
−$9M
−35.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $308.1M | −$95.6K |
| FY24 | $224.5M | −$91.4K |
| FY23 | $136.2M | −$105.9K |
| FY22 | $75M | −$87.2K |
| FY21 | $34.5M | −$59.9K |
| FY20 | $7.7M | −$53M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 63.7% | −33.7% | 0% |
| FY24 | 61.1% | −43% | 0% |
| FY23 | 52.2% | −80.2% | −0.1% |
| FY22 | 49.4% | −107.6% | −0.1% |
| FY21 | 46% | −157.1% | −0.2% |
| FY20 | −16.3% | −619.4% | −687% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$58.3M |
| FY24 | −$103.6M |
| FY23 | −$133.2M |
| FY22 | −$83M |
| FY21 | −$57.9M |
| FY20 | −$48.6M |
| FY19 | - |
- PROCEPT BioRobotics
- Healthcare median
Show the numbers
| Year | PROCEPT BioRobotics | Healthcare median |
|---|---|---|
| FY25 | 0% | −30.6% |
| FY24 | 0% | −47% |
| FY23 | −0.1% | −58% |
| FY22 | −0.1% | −80.4% |
| FY21 | −0.2% | −71.8% |
| FY20 | −687% | −62.2% |
| FY19 | - | −46.2% |